An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

EARLY_PHASE1

Total Enrollment

71 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-23

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial studies the use of a special type of computed (CT) scan called dual energy CT in detecting gastrointestinal carcinoid tumors. CT is an imaging technique that uses x-rays and a computer to create images of areas inside the body. Dual energy computed tomography is a technique used during routine CT scans to help obtain and process the image after the scan is complete. Doctors want to learn if dual energy computed tomography can help improve the detection of carcinoid tumors during routine CT scans.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Energy CT in Imaging and Diagnosis of Gastric Cancer

NCT06869694

Gastric Cancer CT

RECRUITING

Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer

NCT05508126

Gastric Cancer Stage

RECRUITING

A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

NCT04161781

Esophagogastric Cancer Esophagus Cancer Esophageal Cancer +4 more

COMPLETED

FDG-PET-CT and Biomarkers in Esophageal Cancer

NCT00833625

Gastrointestinal Disease Esophageal Cancer

COMPLETED NA

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

NCT04069299

Neuroendocrine Carcinoma

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. Evaluate prospectively the sensitivity and specificity of dual energy computed tomography (CT) in detecting primary gastrointestinal (GI) carcinoid.

OUTLINE:

Patients undergo one dual energy CT scan during scheduled CT scan.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carcinoid Syndrome Carcinoid Tumor Digestive System Neuroendocrine Tumor G1 Metastatic Carcinoid Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diagnostic (dual energy CT scan)

Patients undergo one dual energy CT scan during scheduled CT scan.

Group Type EXPERIMENTAL

Dual-Energy Computed Tomography

Intervention Type PROCEDURE

Undergo dual energy CT scan

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dual-Energy Computed Tomography

Undergo dual energy CT scan

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

DECT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with: clinical features of carcinoid syndrome (or) increased serum and urinary markers suggestive of carcinoid (or) endoscopic biopsy proven carcinoid (or) metastases which are biopsy proven as carcinoid.
* Patient is scheduled to have a clinically indicated staging CT exam.
* Patients who have signed their informed consent form to undergo the study.

Exclusion Criteria

* Patients who have already had their primary GI carcinoid resected.
* Contraindication to intravenous contrast agents (e.g. allergy, renal failure, dialysis, pregnancy etc.).
* Pregnant patients.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No